Tiffany Jackson

Title: Innovations by Tiffany Jackson in Pharmaceutical Formulations

Introduction

Tiffany Jackson is an accomplished inventor based in Baltimore, MD (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of neoplastic diseases. Her innovative work focuses on enhancing humoral immunity in tumors, which is crucial for developing effective cancer therapies.

Latest Patents

Tiffany holds a patent for her invention titled "Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors." This patent presents novel pharmaceutical formulations that include derivatives of NDGA, specifically MN (tetra-0-methyl nordihydroguaiaretic acid) and temozolomide. The formulations aim to inhibit and treat various cancers, including glioblastoma multiforme and lung cancer. Tiffany has 1 patent to her name, showcasing her innovative approach to cancer treatment.

Career Highlights

Throughout her career, Tiffany has worked with prestigious institutions, including The Johns Hopkins University and Academia Sinica. Her experience in these renowned organizations has allowed her to collaborate with leading experts in the field of cancer research and pharmaceutical development.

Collaborations

Tiffany has collaborated with notable colleagues, including Ru Chih C Huang and Jong Ho Chun. These partnerships have contributed to her success in developing groundbreaking pharmaceutical formulations.

Conclusion

Tiffany Jackson's innovative work in pharmaceutical formulations highlights her dedication to advancing cancer treatment. Her contributions are paving the way for new therapies that could significantly impact patient outcomes.